Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
02.08.24
/
50%
€46.20
Target price
02.08.25
€68.71
Performance (%)
0.00%
Price
01.08.24
€41.20
Summary
This prediction is currently active. Wells_Fargo___Compan's BUY prediction for Ultragenyx Pharmaceutical Inc. is currently unchanged. This prediction currently runs until 02.08.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Ultragenyx Pharmaceutical Inc. | 0.00% |
iShares Core DAX® | -3.935% |
iShares Nasdaq 100 | -3.608% |
iShares Nikkei 225® | -4.513% |
iShares S&P 500 | -2.607% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Wells Fargo & Company from $72.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
9.57%
01.08.24
01.08.24